Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2026 vs. Q1 2026
How the institutions holding Terns Pharmaceuticals, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 317 | 4 | 1 | −312 |
| Shares | 124.8M | 1.63M | 1.42K | −123.1M (−100.0%) |
| Value | $6.56B | $85.7M | $75.4K | −$6.48B (−100.0%) |
4 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
None.
Sold out (312)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
Showing the largest 100 of 312 by value.
Not filed for Q2 2026 yet (4)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Janus Henderson Group PLC | 1,470,057 | $77.5M |
| CIBRA Capital Ltd | 151,440 | $7.98M |
| CWM, LLC | 4,172 | $219.9K |
| Sunbelt Securities, Inc. | 71 | $3.74K |